No Data
No Data
兆科眼科-B:2023 年報
Zhaoke Ophthalmology-B (06622.HK): Chen Yu resigns as non-executive director
Zhaoke Ophthalmology-B (06622.HK) announced that Chen Yu has resigned as a non-executive director to spend more time on other work arrangements, effective April 8, 2024.
Annual Report Observation: The second low-concentration atropine produced in China is coming, and the value of Zhaoke Ophthalmology-B (6622.HK) has been rediscovered
The innovative ophthalmology drug market has always been one of the hot areas that the market has paid great attention to, especially in the field of myopic ophthalmology.
Zhaoke Ophthalmological-B (06622.HK) announces annual results, first confirmation that sales revenue is continuing to expand its footprint globally
Gelonghui, March 27 | Zhaoke Ophthalmology-B (06622.HK) announced that the company first confirmed sales revenue in 2023: in 2023, the company recorded total revenue of RMB 18.8 million, of which RMB 4.7 million came from the sale of ophthalmic drugs (including bemesol timolol and Ruibault), while RMB 8.4 million came from the sale of non-prescription ophthalmic products (Baudexi series hot eye masks). Additionally, the company recorded revenue of RMB 5.6 million from distribution transaction payments outside of China. The company's pipeline is equipped with a variety of key innovative drugs that may have significant curative effects, which can be expected in the future
ZHAOKE OPHTH-B: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2023
Zhaoke Ophthalmology-B (06622.HK) was granted FIDELITY CHINA SPECIAL EXCLUSIVE PLC to increase its common shares by 2,822 million shares worth approximately HK$4,573,900
On March 22, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on March 22, FIDELITY CHINA SPECIAL ATTRACTION PLC increased its share holdings of $Zhaoke Ophthalmology-B (06622.HK) by $2,822,000 at an average price of HK$1.6208 per share on March 19, worth approximately HK$4.573,900. After the increase in holdings, FIDELITY CHINA SPECIAL PROVIDES PLC's latest shareholding number was 32.974 million shares, and the good position ratio increased from 5.52% to
No Data